Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. The selection includes GLP-1 care and NAD+ creator messages. The peptide waitlist is a separately sourced page reference. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A dedicated offer page combines pricing presentation, treatment plans, customer stories, care inclusions and the online-care entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
Showing the options side by side answers a question buyers in this category ask early (which one is right for me?) and makes Fridays look like a place with choices rather than a single product. Each item is labeled clearly, and the U.S. News badge adds outside credibility. The copy is short and covers the essentials: brand-name and compounded options, the same care team behind all of them, and plans from $99 a month locked for as long as you stay. Fridays ran several versions of this from October 20, 2026.
The $99 price sits above all the products, but the fine print says it's the starting price for compounded semaglutide, and the landing page lists tirzepatide at a higher price. A viewer who wants Zepbound may click expecting $99. The code is also a mismatch: the ad says use FOREVER12 while the page hero says no code needed. Put a price under each product, and use one code story across ad and page.
Framing the ad as a choice speaks to the buyer who doesn't know which option to pick.
Lining up the options shows range and makes the brand feel like a full-service provider.
The price and badge give a reason to click, though the price only covers one option.
The copy explains that the care stays the same whichever option you choose.
Plans from $99 a month, locked as long as you stay, with code FOREVER12; the fine print ties the price to compounded semaglutide on a 12-month plan.
The ad lands on the price-lock offer page, a focused landing page. The hero coupon says as low as $99 a month with no code needed, and the block below spells out semaglutide at $99 and tirzepatide at a higher starting price, then the plans section compares options. That's the right structure for a choice ad, but the per-product prices arrive after the click instead of in the ad.
A dedicated Fridays offer page for GLP-1 care that opens on a coupon-style card promising as low as $99 a month with forever pricing, then moves through drug prices, plans, customer stories, the care team and safety information. 12 Fridays ads in the library send people here, mostly creator stories and price-lock statics.
A dashed coupon card announces GLP-1 care as low as $99 a month with forever pricing, a countdown and a Lock in my price button, answering what's the deal.
A Now as Low as $99/mo GLP-1 Weight Loss headline lists semaglutide and tirzepatide prices, included clinical care and a two-minute qualification, answering what exactly do I get for that price.
A before-and-after photo pair with a vial sits beside a rating line that cites reviews and a success-rate figure, answering does anyone like this.
A row of media logos (Bloomberg, Forbes, Healthline, WebMD, Fortune, Fast Company) answers is this a company people have heard of.
Plans and a comparison lay out the options side by side, answering which one should I pick.
Stories from customers answer what was it like for someone like me.
This section shows the care that comes with the plan and the clinicians behind it, answering who's actually looking after me.
The steps to get started answer what happens after I click.
Questions and safety details close the page, answering the remaining what-ifs and the required disclosures.
Read the full breakdown of this page
One of 21 Fridays ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.